Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease | Zendy

James A. Blumenthal | Zendy; Patrick J. Smith | Zendy; Wei Jiang | Zendy; Alan L. Hinderliter | Zendy; Lana L. Watkins | Zendy; Benson M. Hoffman | Zendy; William E. Kraus | Zendy; Lawrence Liao | Zendy; Jonathan Davidson | Zendy; Andrew Sherwood | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease

Author(s) -

James A. Blumenthal,

Patrick J. Smith,

Wei Jiang,

Alan L. Hinderliter,

Lana L. Watkins,

Benson M. Hoffman,

William E. Kraus,

Lawrence Liao,

Jonathan Davidson,

Andrew Sherwood

Publication year - 2021

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2021.2236

Subject(s) - escitalopram , anxiety , medicine , randomized controlled trial , placebo , heart rate , physical therapy , hospital anxiety and depression scale , psychiatry , blood pressure , alternative medicine , pathology , antidepressant

Anxiety is common among patients with coronary heart disease (CHD) and is associated with worse health outcomes; however, effective treatment for anxiety in patients with CHD is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research